Vidwan-ID : 164354

Edit Profile

Academic

Orcid Id 0000-0002-3333-2672
Scopus Id 55482385500
Researcher Id AEW-3700-2022
Google Scholar Id dAwwV2oAAAAJ

Score criteria

Criteria	Point
Personal Details	1
Expertise Details	1
Experience Details	1
Qualification Details	1
Employee ID	0.2
Orcid ID	0.2
Researcher ID	0.2
Scopus ID	0.2
Google Scholar ID	0.2
Honours <=3< /td>	0.3
Honours >3	0.5
Project worth less than Rs.5,00,000/-	0.2
Project worth more than Rs.5,00,000/-	0.5
Membership in professional Bodies < 5	0.5
Membership in professional bodies >=5	1
No of publications <=15	1
No of publications between 15-45	2
No of publications >45	3

Vidwan Score 8.2

345 Articles

15 Conferences

3 Projects

Prof MOHD AKHTAR

Professor

Jamia Hamdard

Publications

345

Journal Articles
15

In Proceedings
15

Conference
Proceedings
3

Projects
7
3
3
37

Citations / H-Index

1142 Citations

26 h-index

1019 Citations

Altmetrics

1422

Google Scholar

Co-author Network

Expertise

Pharmacology and Pharmacy

Personal Information

Prof MOHD AKHTAR

Male

JAMIA HAMDARD MB ROAD Jamia Hamdard, Hamdard Nagar

New Delhi, Delhi, India - 110062

Experience

2020 - Present

Professor

Department of Pharmacology

Jamia Hamdard, South Delhi
2017 - 2020

Associate Professor

Department of Pharmacology

Jamia Hamdard, South Delhi
2002 - 2005

Assistant Professor

Department of Pharmacology

Jamia Hamdard,

Qualification

2006

PH.D

JAMIA HAMDARD
1997

M.PHARM

JAMIA HAMDARD
1995

B.PHARM

JAMIA HAMDARD

Doctoral Theses Guided

2022

Evaluation of Phosphodiesterase inhibitors in experimental models of Alzheimer’s disease.

JAMIA HAMDARD,NOORUL HASAN

2020

Identification of natural PDE inhibitors and their neuroprotective mechanisms in experimental vascular dementia and Alzheimer’s disease.

JAMIA HAMDARD,MADHU

2020

Synthesis and Characterization of functionalized Collagen nanopartieles and their applications in drug delivery.

JAMIA HAMDARD,PANKAJ RATHOD

2022

Evaluation of Phosphodiesterase inhibitors in experimental models of Alzheimer’s disease.

JAMIA HAMDARD,NOORUL HASAN

2020

Identification of natural PDE inhibitors and their neuroprotective mechanisms in experimental vascular dementia and Alzheimer’s disease.

JAMIA HAMDARD,MADHU

2020

Synthesis and Characterization of functionalized Collagen nanopartieles and their applications in drug delivery.

JAMIA HAMDARD,PANKAJ RATHOD

2020

Evaluation of alendronate and its intranasal formulation in experimental models of Alzheimer’s disease.

JAMIA HAMDARD,SAIMA ZAMEER

2019

Evaluation of standardized nanocarrier based thymoquinone formulation in animal models of depression

JAMIA HAMDARD,MAHTAB ALAM

2019

Effect of phthalate esters on glucocorticoid metabolite pathway and pro-inflammatory cytokines

JAMIA HAMDARD,SHAHZAD AHMAD

2018

Neuroprotective potential of rosuvastatin and Emblica officinalis on high salt and high cholesterol diet induced neuroinflammation and cognitive impairment.

JAMIA HAMDARD,IBRAHIM HUSSAIN

2017

Synthesis of various types of nanoplymers and their biological applications.

JAMIA HAMDARD,SHASHI KUMAR VERMA

2016

Study of guggulipid in animal model of focal cerebral ischemia.

JAMIA HAMDARD,MOHD AFROZ AHMAD

2016

Cardioprotective effects of histamine H3 agonists in rodents: Role of rennin angiotensin system.

JAMIA HAMDARD,CHANDER HASS

2015

Evaluation of histamine H3 receptor ligands in experimental models of schizophrenia.

JAMIA HAMDARD,DANISH MAHMOOD

2014

Vesicular Transdermal drug delivery systems of an atypical anti-psychotic agent for the management of schizophrenia.

JAMIA HAMDARD,SARIM IMAM

2014

Pharmacognostical and Pharmacological evaluation of some herbal drugs used in traditional system of medicine for liver disorders.

JAMIA HAMDARD,MOHD AMIR

2013

A bioequivalence study comparing generic levofloxacin 500 mg tablets with Cravit 500 mg tablets in healthy, adult, human subjects.

JAMIA HAMDARD,Raj Karan Seth

Read Less

Research Projects

Evaluation of guggulipid extract in animal model of focal cerebral ischemia in rats

Funding Agency : UGC

Preparation and Development of Drug Formulation of Nigella sativa with therapeutic potential in stroke

Funding Agency : AICTE

Selective Histamine H3 receptor antagonists: A promising novel target for schizophrenia

Funding Agency : DST

Evaluation of guggulipid extract in animal model of focal cerebral ischemia in rats

Funding Agency : UGC

Preparation and Development of Drug Formulation of Nigella sativa with therapeutic potential in stroke

Funding Agency : AICTE

Selective Histamine H3 receptor antagonists: A promising novel target for schizophrenia

Funding Agency : DST

Read Less

Vidwan-ID : 164354

Academic

Score criteria

Vidwan Score 8.2

Prof MOHD AKHTAR

Publications

Journal Articles

In Proceedings

Conference Proceedings

Projects

Citations / H-Index

Altmetrics

Google Scholar

Co-author Network

Publications - 302 Co-author - 456

Expertise

Pharmacology and Pharmacy

Pharmacology and Pharmacy

Personal Information

Prof MOHD AKHTAR

Experience

Professor

Associate Professor

Assistant Professor

Qualification

PH.D

M.PHARM

B.PHARM

Doctoral Theses Guided

Evaluation of Phosphodiesterase inhibitors in experimental models of Alzheimer’s disease.

Identification of natural PDE inhibitors and their neuroprotective mechanisms in experimental vascular dementia and Alzheimer’s disease.

Synthesis and Characterization of functionalized Collagen nanopartieles and their applications in drug delivery.

Evaluation of Phosphodiesterase inhibitors in experimental models of Alzheimer’s disease.

Identification of natural PDE inhibitors and their neuroprotective mechanisms in experimental vascular dementia and Alzheimer’s disease.

Synthesis and Characterization of functionalized Collagen nanopartieles and their applications in drug delivery.

Evaluation of alendronate and its intranasal formulation in experimental models of Alzheimer’s disease.

Evaluation of standardized nanocarrier based thymoquinone formulation in animal models of depression

Effect of phthalate esters on glucocorticoid metabolite pathway and pro-inflammatory cytokines

Neuroprotective potential of rosuvastatin and Emblica officinalis on high salt and high cholesterol diet induced neuroinflammation and cognitive impairment.

Synthesis of various types of nanoplymers and their biological applications.

Study of guggulipid in animal model of focal cerebral ischemia.

Cardioprotective effects of histamine H3 agonists in rodents: Role of rennin angiotensin system.

Evaluation of histamine H3 receptor ligands in experimental models of schizophrenia.

Vesicular Transdermal drug delivery systems of an atypical anti-psychotic agent for the management of schizophrenia.

Pharmacognostical and Pharmacological evaluation of some herbal drugs used in traditional system of medicine for liver disorders.

A bioequivalence study comparing generic levofloxacin 500 mg tablets with Cravit 500 mg tablets in healthy, adult, human subjects.

Research Projects

Evaluation of guggulipid extract in animal model of focal cerebral ischemia in rats

Funding Agency : UGC

Preparation and Development of Drug Formulation of Nigella sativa with therapeutic potential in stroke

Funding Agency : AICTE

Selective Histamine H3 receptor antagonists: A promising novel target for schizophrenia

Funding Agency : DST

Evaluation of guggulipid extract in animal model of focal cerebral ischemia in rats

Funding Agency : UGC

Preparation and Development of Drug Formulation of Nigella sativa with therapeutic potential in stroke

Funding Agency : AICTE

Selective Histamine H3 receptor antagonists: A promising novel target for schizophrenia

Funding Agency : DST

Publications (302)

Contact Us

Conference
Proceedings